Patents Assigned to 6J Biotechnology (Hong Kong) Limited
  • Patent number: 11986482
    Abstract: Methods of inhibiting endosomal trafficking of PD-L1, inducing PD-L1 secretion via exosomes, decreasing PD-L1 level at a surface of a cancer or tumor cell, and treating a cancer or tumor through promoting T cell immune response in a subject suffering from a cancer or tumor, includes the step of administering a compound of Formula I to various cells. Also, a composition to treat a cancer or a tumor, includes a compound of Formula I and an anti-PD-1 antibody.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: May 21, 2024
    Assignees: City University of Hong Kong, 6J Biotechnology (Hong Kong) Limited
    Inventors: Jianbo Yue, Qingru Zhang, Zuodong Ye, Wang Peng
  • Patent number: 11357771
    Abstract: A method of preventing or treating a subject suffering from a flavivirus infection by administering an effective amount of berbamine or its analogue to the subject, berbamine has a structure of Formula (I), wherein the flavivirus infection is caused by Japanese encephalitis virus, Zika virus or Dengue virus. A method of inhibiting the entry of a flavivirus, an enterovirus and/or a lentivirus into host cells includes contacting the host cells with an effective amount of berbamine of its analogue, berbamine has a structure of Formula (I), wherein the flavivirus is Japanese encephalitis virus, Zika virus or Dengue virus.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: June 14, 2022
    Assignees: City University of Hong Kong, 6J Biotechnology (Hong Kong) Limited
    Inventors: Jianbo Yue, Lihong Huang